Expanded test for genetic predisposition to inherited cancer diseases

Cancer hereditary predisposition is caused by gene mutations that can be passed from parent to child, thus increasing the childโ€™s risk of developing cancer. At Bioscience Institute, the critical goal is to intercept cancer predisposition before its development to give the opportunity to maximize health outcomes for patients.

Individuals with a family history of cancer may have an increased risk of cancer if they have inherited a cancer-causing mutation.

Brochure MyCheck Cancer

MyCheck Cancer tests

Using Next-Generation Sequencing (NGS)-based assays, we offer a variety of options, including targeted panels that analyze genes directly linked to specific cancers through scientific research. Our MyCheck tests are used to detect specific, heritable, disease-related gene mutations that may increase the risk of certain cancers allowing an in-depth cancer risk assessment for each patient.

MyEndom

MyEndom is a non-invasive test for the screening of endometrial cancer and precancerous lesions. It can identify anomalies which, if confirmed by hysteroscopy, allow the early diagnosis of endometrial cancer.

MyColon

MyColon is a non-invasive test for the screening of colorectal cancer and precancerous lesions. It can detect abnormalities which, if confirmed by a colonoscopy, allow for the early diagnosis of colorectal cancer.

MyCheck Breast

When a mutation occurs in the BRCA genes that prevent them from working normally, it raises a personโ€™s risk for breast cancers. The MyCheck Breast test is done to determine if you have changes in your DNA that increase the risk of this cancer.

×

Information Request








    Privacy Policy (*)

    ×

    Richiesta Informazioni








      Privacy Policy (*)